Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-009055

Chief Financial Officer sold 1,759 shares at $20.39 ($35,866)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Koppikar Utpal Chief Financial Officer 2021-02-08 Sale −1,759 $20.39 $35,866 130,546 D
Open-market sales · 1,759 sh · avg $20.39 · $35,866
Loading xslF345X03/doc4.xml…